Long-term survival in advanced melanoma patients using repeated therapies: successive immunomodulation improving the odds?

BACKGROUND: Patients with advanced metastatic melanoma are often confronted with little prospect of medium- to longer-term survival by any currently available therapeutic means. However, most clinicians are aware of exceptional cases where survival defies the notion of futility. Prolonged survival f...

Descripción completa

Detalles Bibliográficos
Autores principales: Coventry, Brendon J, Baume, Dominique, Lilly, Carrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425244/
https://www.ncbi.nlm.nih.gov/pubmed/25995649
http://dx.doi.org/10.2147/CMAR.S76163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425244/
https://www.ncbi.nlm.nih.gov/pubmed/25995649
http://dx.doi.org/10.2147/CMAR.S76163

Ejemplares similares